Search - tctmd.com

Displaying 21 - 40 of 64

Sort: Relevancy | Date

Presentation TCT 2017

Emerging TMVR 2: 4C - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, Philippe Genereux

October 31, 2017

Presentation TCT 2017

Emerging TMVR 1: Cephea - Device Description, Critical Appraisal, and Development Plans

Presenter: Juan F. Granada

October 31, 2017

Presentation TCT 2017

Established TMVR 6: Caisson - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Mathew Williams

October 31, 2017

Presentation TCT 2017

Established TMVR 5: Highlife - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Nicolo Piazza

October 31, 2017

Presentation TCT 2017

Established TMVR 4: Intrepid - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Vinayak Bapat

October 31, 2017

Presentation TCT 2017

Established TMVR 3: Tendyne - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, David W.M. Muller

October 31, 2017

Presentation TCT 2017

Established TMVR 2: Tiara - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Anson Cheung

October 31, 2017

Presentation TCT 2017

Established TMVR 1: Cardiaq - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, James B. Hermiller Jr.

October 31, 2017

Presentation TCT 2017

Keynote Address: Grand Summary of the Vast TMVR Landscape - Differentiating Features and Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Bernard Prendergast

October 31, 2017

Presentation TCT 2017

TCT 55: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction (LAMPOON) During TMVR: First-in-Human Findings

Presenter: Karl-Heinz Kuck, Nicolo Piazza, Jaffar M Khan

October 31, 2017

Presentation TCT 2017

Editorial Perspective: The TMVR Field: Unmet Technological Needs, Competitive Landscape and Future Opportunities

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Vinayak Bapat

October 31, 2017

Presentation TCT 2017

CT Imaging Essentials for Patient Selection of Mitraclip, Transcatheter Annuloplasty, and TMVR Procedures

Presenter: Paul A. Grayburn, Maurice E. Sarano, Jonathon A. Leipsic

October 30, 2017

Presentation TCT 2017

TEE Imaging Essentials for Patient Selection of Mitraclip, Transcatheter Annuloplasty, and TMVR Procedures

Presenter: Paul A. Grayburn, Maurice E. Sarano

October 30, 2017

News Opinion Fellow Talk

My Picks for Fellows Attending TCT 2017

Amit K. Gupta, MBBS, MD

October 26, 2017

Presentation PCR London Valves 2017

Screening and Selecting Patients for TMVR

Presenter: Vinayak Bapat

September 26, 2017

News Daily News

After Failed Mitral Valve Surgery, Transcatheter Valve-in-Valve or Valve-in-Ring Shows Promise in High-Risk Patients

Yael L. Maxwell

August 24, 2017

Presentation

Transcatheter Mitral Valve Replacement (TMVR) for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings

August 24, 2017

News Industry News

4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec

July 20, 2017

Presentation TVT 2017

Can We Avoid LVOT Obstruction? LAMPOON Procedure

Presenter: Neil E. Moat, Adam B. Greenbaum

June 16, 2017

Presentation TVT 2017

Can LVOT Obstruction Be Avoided? Lessons Learned From MAC

Presenter: Neil E. Moat, Mayra Guerrero

June 16, 2017

Advertisement

Emerging TMVR 2: 4C - Device Description, Critical Appraisal, and Development Plans

Emerging TMVR 1: Cephea - Device Description, Critical Appraisal, and Development Plans

Established TMVR 6: Caisson - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 5: Highlife - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 4: Intrepid - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 3: Tendyne - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 2: Tiara - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 1: Cardiaq - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Keynote Address: Grand Summary of the Vast TMVR Landscape - Differentiating Features and Outcomes

TCT 55: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction (LAMPOON) During TMVR: First-in-Human Findings

Editorial Perspective: The TMVR Field: Unmet Technological Needs, Competitive Landscape and Future Opportunities

CT Imaging Essentials for Patient Selection of Mitraclip, Transcatheter Annuloplasty, and TMVR Procedures

TEE Imaging Essentials for Patient Selection of Mitraclip, Transcatheter Annuloplasty, and TMVR Procedures

My Picks for Fellows Attending TCT 2017

Screening and Selecting Patients for TMVR

After Failed Mitral Valve Surgery, Transcatheter Valve-in-Valve or Valve-in-Ring Shows Promise in High-Risk Patients

Transcatheter Mitral Valve Replacement (TMVR) for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings

4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec

Can We Avoid LVOT Obstruction? LAMPOON Procedure

Can LVOT Obstruction Be Avoided? Lessons Learned From MAC

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content